Home
BRNS
BRNS News

Latest Barinthus Biotherapeutics plc (BRNS) News on June 27, 2025

Q2 Virtual Investor Summit: Presentations Available Now

ACCESS Newswire

2 days ago

Q2 Virtual Investor Summit: Presentations Available Now

ACCESS Newswire

18 days ago

Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025

Metalpha Technology Holding And 2 Other Promising Penny Stocks

Simply Wall St.

25 days ago

Metalpha Technology Holding And 2 Other Promising Penny Stocks

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

GlobeNewswire

2 months ago

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

Here's Why We're Not Too Worried About Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation

Simply Wall St.

2 months ago

Here's Why We're Not Too Worried About Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

GlobeNewswire

3 months ago

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

ACCESS Newswire

3 months ago

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

ACCESS Newswire

4 months ago

Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11

US Exchange Insights: 3 Penny Stocks With Over $40M Market Cap

Simply Wall St.

5 months ago

US Exchange Insights: 3 Penny Stocks With Over $40M Market Cap

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

GlobeNewswire

6 months ago

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar

Simply Wall St.

6 months ago

Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar

Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer

GlobeNewswire

7 months ago

Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

GlobeNewswire

7 months ago

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

GlobeNewswire

7 months ago

Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

GlobeNewswire

8 months ago

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences

GlobeNewswire

8 months ago

Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences

ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch

Simply Wall St.

8 months ago

ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

GlobeNewswire

9 months ago

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

GlobeNewswire

9 months ago

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

GlobeNewswire

a year ago

Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

GlobeNewswire

a year ago

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

Here's Why We're Watching Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Watching Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

GlobeNewswire

a year ago

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

GlobeNewswire

a year ago

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024

GlobeNewswire

a year ago

Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments

GlobeNewswire

a year ago

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments

Increases to CEO Compensation Might Be Put On Hold For Now at Barinthus Biotherapeutics plc (NASDAQ:BRNS)

Simply Wall St.

a year ago

Increases to CEO Compensation Might Be Put On Hold For Now at Barinthus Biotherapeutics plc (NASDAQ:BRNS)

Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer

GlobeNewswire

a year ago

Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections

GlobeNewswire

a year ago

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections

Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments

GlobeNewswire

a year ago

Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%

Zacks

a year ago

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%

High Tide To Open First Canna Cabana Store in Fort McMurray, Alberta

PR Newswire

a year ago

High Tide To Open First Canna Cabana Store in Fort McMurray, Alberta

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

GuruFocus.com

a year ago

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

Hepsiburada Announces Changes to its Board of Directors

GlobeNewswire

a year ago

Hepsiburada Announces Changes to its Board of Directors

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

Zacks

a year ago

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

CNW Group

a year ago

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

IperionX Letter to Shareholders

Business Wire

a year ago

IperionX Letter to Shareholders

Is Erasca (NASDAQ:ERAS) In A Good Position To Invest In Growth?

Simply Wall St.

a year ago

Is Erasca (NASDAQ:ERAS) In A Good Position To Invest In Growth?

Kopin Receives $20.5 Million Contract for New Thermal Weapon Sight Configuration

Business Wire

a year ago

Kopin Receives $20.5 Million Contract for New Thermal Weapon Sight Configuration

Investing.com

a year ago

Shoe retailer Genesco cuts full-year earnings forecast, shares plunge premarket

Here’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)

Insider Monkey

a year ago

Here’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)

Shuffle Board: Gozen Taps Orta Exec, Genesco Names Journeys EVP

Sourcing Journal

a year ago

Shuffle Board: Gozen Taps Orta Exec, Genesco Names Journeys EVP

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

GlobeNewswire

a year ago

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

GlobeNewswire

a year ago

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

GlobeNewswire

a year ago

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Kopin Corporation and MICLEDI Microdisplays Announce Agreement to Collaborate on microLED Displays for Next Generation Vision Solutions

Business Wire

a year ago

Kopin Corporation and MICLEDI Microdisplays Announce Agreement to Collaborate on microLED Displays for Next Generation Vision Solutions

New partnership aims to advance vaccine against MERS coronavirus

GlobeNewswire

2 years ago

New partnership aims to advance vaccine against MERS coronavirus

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

Business Wire

2 years ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

12 Most Promising Cancer Stocks According to Analysts

Insider Monkey

2 years ago

12 Most Promising Cancer Stocks According to Analysts

There's Reason For Concern Over Ardelyx, Inc.'s (NASDAQ:ARDX) Massive 36% Price Jump

Simply Wall St.

2 years ago

There's Reason For Concern Over Ardelyx, Inc.'s (NASDAQ:ARDX) Massive 36% Price Jump

Co-Founder of Cibus Picks Up 23% More Stock

Simply Wall St.

2 years ago

Co-Founder of Cibus Picks Up 23% More Stock

Cibus Announces $20.3 Million Registered Direct Offering

GlobeNewswire

2 years ago

Cibus Announces $20.3 Million Registered Direct Offering

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma

GlobeNewswire

2 years ago

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma

Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares

GuruFocus.com

2 years ago

Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Analysts Expect Breakeven For nCino, Inc. (NASDAQ:NCNO) Before Long

Simply Wall St.

2 years ago

Analysts Expect Breakeven For nCino, Inc. (NASDAQ:NCNO) Before Long

GlobeNewswire

2 years ago

Kandi Technologies Announces Share Buyback of Up to $30 Million

Individual investors account for 39% of enGene Holdings Inc.'s (NASDAQ:ENGN) ownership, while private equity firms account for 37%

Simply Wall St.

2 years ago

Individual investors account for 39% of enGene Holdings Inc.'s (NASDAQ:ENGN) ownership, while private equity firms account for 37%

Declining Stock and Decent Financials: Is The Market Wrong About Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Simply Wall St.

2 years ago

Declining Stock and Decent Financials: Is The Market Wrong About Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Kandi’s First 500 Fully Electric Mini Golf Carts to Launch in US Market

GlobeNewswire

2 years ago

Kandi’s First 500 Fully Electric Mini Golf Carts to Launch in US Market

Live Oak Bancshares Announces Executive Appointments, Including Walter J. Phifer Named as Chief Financial Officer

GlobeNewswire

2 years ago

Live Oak Bancshares Announces Executive Appointments, Including Walter J. Phifer Named as Chief Financial Officer

GlobeNewswire

2 years ago

Kandi America Partners with Peavey Mart to Expand Kandi Products into Canada

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

GlobeNewswire

2 years ago

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

GlobeNewswire

2 years ago

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

GlobeNewswire

2 years ago

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

Kandi Technologies Group, Inc. (NASDAQ:KNDI) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Kandi Technologies Group, Inc. (NASDAQ:KNDI) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Latham Group Inc Earnings Call

GuruFocus.com

2 years ago

Latham Group Inc (SWIM) Reports 15.1% Decrease in Q3 Net Sales, Adjusted EBITDA Margin Improves

Associated Press Finance

2 years ago

Latham Group: Q3 Earnings Snapshot

Lyra Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

2 years ago

Lyra Therapeutics to Participate in Upcoming Investor Conferences

Twin Disc, Incorporated (NASDAQ:TWIN) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Twin Disc, Incorporated (NASDAQ:TWIN) Q1 2024 Earnings Call Transcript

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

Business Wire

2 years ago

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

Share on Social Networks: